UiPath (NYSE:PATH) Stock Price Up 1%

UiPath Inc. (NYSE:PATH) shares rose 1% during mid-day trading on Monday . The company traded as high as $12.92 and last traded at $12.81. Approximately 2,235,723 shares were traded during trading, a decline of 77% from the average daily volume of 9,877,016 shares. The stock had previously closed at $12.68.

Analyst Ratings Changes

PATH has been the subject of a number of recent analyst reports. Royal Bank of Canada restated a “sector perform” rating and set a $29.00 price objective on shares of UiPath in a report on Monday, April 1st. BMO Capital Markets dropped their price objective on UiPath from $28.00 to $14.00 and set a “market perform” rating for the company in a report on Monday, June 3rd. Barclays lowered their target price on UiPath from $25.00 to $16.00 and set an “equal weight” rating for the company in a report on Thursday, May 30th. Needham & Company LLC reiterated a “hold” rating on shares of UiPath in a report on Thursday, May 30th. Finally, Bank of America reiterated a “neutral” rating and issued a $16.00 target price (down from $30.00) on shares of UiPath in a report on Thursday, May 30th. Sixteen analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $18.06.

UiPath Trading Up 1.5 %

The stock has a market cap of $7.37 billion, a price-to-earnings ratio of -80.63 and a beta of 0.86. The stock has a 50-day moving average price of $16.18 and a two-hundred day moving average price of $20.75.

UiPath (NYSE:PATH) last posted its quarterly earnings data on Wednesday, May 29th. The healthcare company reported ($0.03) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.03). The firm had revenue of $335.11 million during the quarter, compared to analysts’ expectations of $332.84 million. UiPath had a negative return on equity of 2.97% and a negative net margin of 6.41%. Research analysts predict that UiPath Inc. will post -0.2 earnings per share for the current fiscal year.

Insider Transactions at UiPath

In related news, CFO Ashim Gupta sold 40,000 shares of the firm’s stock in a transaction on Monday, May 6th. The stock was sold at an average price of $19.79, for a total value of $791,600.00. Following the completion of the transaction, the chief financial officer now owns 946,848 shares in the company, valued at approximately $18,738,121.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 22.37% of the company’s stock.

Hedge Funds Weigh In On UiPath

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Intech Investment Management LLC raised its stake in UiPath by 3.1% in the 4th quarter. Intech Investment Management LLC now owns 14,324 shares of the healthcare company’s stock worth $356,000 after acquiring an additional 426 shares during the last quarter. 180 Wealth Advisors LLC raised its stake in shares of UiPath by 0.3% during the 4th quarter. 180 Wealth Advisors LLC now owns 188,950 shares of the healthcare company’s stock valued at $4,497,000 after buying an additional 492 shares during the last quarter. Global Financial Private Client LLC raised its stake in shares of UiPath by 9.3% during the 1st quarter. Global Financial Private Client LLC now owns 6,471 shares of the healthcare company’s stock valued at $144,000 after buying an additional 551 shares during the last quarter. Bleakley Financial Group LLC raised its stake in shares of UiPath by 4.9% during the 4th quarter. Bleakley Financial Group LLC now owns 12,691 shares of the healthcare company’s stock valued at $315,000 after buying an additional 598 shares during the last quarter. Finally, Simplicity Solutions LLC raised its stake in shares of UiPath by 4.9% during the 4th quarter. Simplicity Solutions LLC now owns 12,691 shares of the healthcare company’s stock valued at $315,000 after buying an additional 598 shares during the last quarter. Hedge funds and other institutional investors own 62.50% of the company’s stock.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.